secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001558370-22-006628
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q1 revenue $48.0M (+12% YoY); net loss $15.6M vs $2.3M loss YoY
-------------------------------------------------------------------------------

- Revenue $48.0M (+12% YoY); net loss $15.6M ($0.78 diluted EPS) vs $2.3M ($0.12) in Q1 2021.
- Operating loss $14.9M vs $4.1M YoY; non-GAAP operating loss $5.4M vs $3.1M.
- Adjusted EBITDA loss $2.6M vs $7K loss YoY.
- Reaffirmed FY2022 revenue guidance $235M-$240M (13-15% growth).
- Airway clearance product line contributed $7.3M revenue; lymphedema product line declined 5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022006628/0001558370-22-006628-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022006628/tcmd-20220502x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-006628

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer